Clinical Trial Update: A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus [Phase 1, Phase 2]

View source ↗

Summary

A clinical study (Phase 1/2) evaluating the safety and efficacy of OPF-310 porcine pancreatic cells in patients with Type 1 diabetes mellitus, currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• OPF-310

Snippet

Sponsor: Otsuka Pharmaceutical Factory, Inc. | Conditions: Diabetes Mellitus, Type 1, Hypoglycemia | Phase 1, Phase 2 | Status: RECRUITING